Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01518413
Recruitment Status : Completed
First Posted : January 26, 2012
Last Update Posted : February 27, 2015
Information provided by (Responsible Party):
HMeany, Children's Research Institute

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2015
  Study Completion Date : January 2015